InvestorsHub Logo
Followers 1
Posts 206
Boards Moderated 0
Alias Born 04/06/2013

Re: None

Tuesday, 03/07/2017 6:53:40 AM

Tuesday, March 07, 2017 6:53:40 AM

Post# of 15766
MAST Investor presentation is all focused on Savara drugs and trials. It seems that AIR001, a potential blockbuster in HF, is nearly missing , oly interested in the new application on Cystic Fibrosis against lung infection of P. Aeureginosa. A complementary drug in Savara pipeline.
I'm disappointed about this , because Mast's pipeline value is just alike that of Savara.
Culley has once again revealed his true colours as an inept CEO, that wasted money of his investors for years and years , even unable to carry out a fair merger.

It's better to vote NO at the merger.


http://seekingalpha.com/article/4052271-mast-therapeutics-mstx-investor-presentation-slideshow